Hello! Welcome back to our module on coagulation studies.
In the last lesson, we built a foundational map of the coagulation cascade and learned how to use the PT/INR and PTT to localize a defect to the extrinsic, intrinsic, or common pathways. We saw how different patterns of abnormal results point to different parts of the cascade.
Today, we're going to apply that framework to two of the most important and common clinical scenarios you'll encounter that cause these abnormalities. Your goal for this lesson is to learn to correlate the effects of vitamin K deficiency and liver disease with PT/INR and PTT results. By the end, you will be able to recognize the specific lab signatures of these conditions and understand how to differentiate between them.
The Central Role of the Liver and Vitamin K
Before we dive into the specific patterns, let's quickly reinforce a key concept: the liver is the factory for almost all clotting factors.
Coagulation screen interpretation | blood test analysis MADE EASY!
This short clip from the 'Medicine Made Simple' channel highlights the liver's central role in synthesizing the proteins we measure with coagulation tests.
Watch from the beginning to 0:28, and then from 2:12 to 3:00. Note how the video directly links liver disease and vitamin K deficiency to a prolonged PT.
This sets the stage for our two main topics. Both vitamin K deficiency and liver disease disrupt the production of functional clotting factors, but they do so in ways that leave distinct diagnostic clues in the lab work.
1. Vitamin K Deficiency
Vitamin K is a fat-soluble vitamin essential for the function of several key clotting factors. It acts as a cofactor for an enzyme that adds a carboxyl group to factors II, VII, IX, and X. Without this step, these factors are synthesized by the liver but remain inactive.
This process, and the consequences of its failure, are explained very clearly in the following video.
Coagulopathy | Clinical Medicine
The Ninja Nerd 'Coagulopathy' video provides a detailed, clinically relevant explanation of vitamin K deficiency. It covers the causes, the underlying biochemistry, and how it translates to specific lab findings.
Please watch from 30:20 to 38:31. As you watch, focus on: The main causes of vitamin K deficiency (e.g., malabsorption, antibiotics). Why Factor VII is the first to be affected, and how this impacts the PT/INR initially.
The Lab Signature of Vitamin K Deficiency
As the video explained, the key to understanding the lab pattern is the half-life of the clotting factors.
- Factor VII has the shortest half-life (around 6 hours).
- The other vitamin K-dependent factors (IX, X, II) have much longer half-lives (24-72 hours).
This leads to a classic two-stage pattern:
- Early/Mild Deficiency: Factor VII levels drop first. Since Factor VII is in the extrinsic pathway, this causes an isolated prolongation of the PT/INR. The PTT, which measures the intrinsic pathway, remains normal.
- Severe/Late Deficiency: As the deficiency continues, levels of factors IX, X, and II also fall. The decrease in Factor IX (intrinsic pathway) and Factors X and II (common pathway) now causes the PTT to become prolonged as well.
So, the full picture is:
- Early Vit K Deficiency → ↑ PT/INR, Normal PTT
- Severe Vit K Deficiency → ↑ PT/INR, ↑ PTT
This progression is nicely summarized in the resource below.
The 'Coagulation' guide from Transfusion Ontario has a very practical section on differential diagnosis. Please read the part that describes the workup for an isolated prolonged PT/INR.
Find the heading 'Prolonged PT / INR with normal APTT' (page 26). Read this short section to reinforce why early vitamin K deficiency presents this way.
2. Liver Disease
As we've established, the liver synthesizes most coagulation factors. Therefore, significant liver dysfunction (cirrhosis, acute liver failure) impairs the production of factors in all three pathways.
The Lab Signature of Liver Disease
Much like with vitamin K deficiency, the short half-life of Factor VII plays a crucial role.
- Early/Mild Liver Disease: The first factor to be depleted is Factor VII. This leads to an isolated prolonged PT/INR. This is precisely why the INR is an excellent measure of the liver's synthetic function and is included in prognostic scores like the MELD score for liver disease.
- Severe/Chronic Liver Disease: As the disease progresses, the liver fails to produce adequate amounts of other factors, including those in the intrinsic and common pathways (e.g., II, V, IX, X). This results in prolongation of both the PT/INR and the PTT.
So, the pattern looks very similar to vitamin K deficiency:
- Early Liver Disease → ↑ PT/INR, Normal PTT
- Severe Liver Disease → ↑ PT/INR, ↑ PTT
Let's watch a segment that explains the impact of cirrhosis on coagulation.
Coagulopathy | Clinical Medicine
Let's return to the Ninja Nerd video to see the explanation for coagulopathy in cirrhosis.
Watch from 48:03 to 52:03. Pay close attention to two key points: Which factor's production is spared in liver disease? What other hematologic abnormality is common in cirrhosis and why?
The coagulopathy of liver disease is complex. The liver also produces natural anticoagulants (like Protein C and S) and clears activated clotting factors. In chronic liver disease, the production of both pro-coagulants and anticoagulants is decreased, leading to a fragile, "re-balanced" state that can easily tip towards either bleeding or clotting.
Test your understanding!
A 58-year-old man with a long history of alcohol abuse is admitted with ascites and jaundice. His labs are:
- PT/INR: 1.8
- PTT: 45 seconds (Normal 25-35s)
- Platelets: 95 x 109/L (Normal 150-400)
Which coagulation factors are likely deficient? What is the cause of his thrombocytopenia?
Show answer
With both the PT/INR and PTT prolonged, there is likely a deficiency in multiple factors across the common and intrinsic/extrinsic pathways (e.g., II, V, VII, IX, X). The thrombocytopenia is likely due to hypersplenism (splenic sequestration of platelets) caused by portal hypertension, as well as decreased thrombopoietin production by the failing liver.
Clinical Synthesis: Differentiating Liver Disease and Vitamin K Deficiency
You've probably noticed a problem: severe vitamin K deficiency and severe liver disease can produce the exact same screening lab pattern (prolonged PT/INR and PTT). So how do we tell them apart?
There are two key differentiating tests:
-
Factor V Level: Factor V is synthesized in the liver but is not vitamin K-dependent.
- In liver disease, Factor V production is impaired, so its level will be low.
- In vitamin K deficiency, Factor V production is unaffected, so its level will be normal.
-
Therapeutic Trial of Vitamin K: Administering vitamin K will help the liver synthesize active factors.
- In vitamin K deficiency, the liver is healthy. Giving vitamin K will allow it to produce functional factors II, VII, IX, and X, and the PT/INR will correct (normalize) within 12-24 hours.
- In severe liver disease, the factory itself is broken. Giving vitamin K won't help if the hepatocytes can't synthesize the factor proteins in the first place. The PT/INR will show little or no correction.
This diagnostic approach is critical in clinical practice. The following resource provides a superb walkthrough.
The 'HEMOSTASIS MANUAL' from Johns Hopkins Pathology is an authoritative guide. We'll read the sections that explicitly lay out the causes for prolonged coagulation tests.
First, read the paragraph under 'Possible Results & Interpretation' for the Prothrombin Time (PT) and INR (starts on page 9). Then, read the same paragraph for the Partial Thromboplastin Time (PTT) (starts on page 11). These sections confirm that severe liver disease and severe vitamin K deficiency cause both tests to be prolonged.
Now let's synthesize this information with a clear algorithmic approach.
Coagulopathy | Clinical Medicine
Finally, let's watch the diagnostic strategy portion of the Ninja Nerd video. This puts everything together and shows you how to work through a patient with prolonged clotting times.
Watch from 1:01:09 to 1:05:49. Follow the logic of using a 'vitamin K trial' to differentiate the causes of a prolonged PT/INR and PTT.
Here is a summary table for differentiating the common causes of a combined PT/INR and PTT elevation:
| Feature | Severe Vitamin K Deficiency | Severe Liver Disease | DIC (from previous lesson) |
|---|---|---|---|
| PT/INR & PTT | Both Prolonged | Both Prolonged | Both Prolonged |
| Response to Vit K | Corrects | No/Partial Correction | No Correction |
| Factor V Level | Normal | Low | Low (consumed) |
| Factor VIII Level | Normal | Normal/High | Low (consumed) |
| Platelets | Normal | Often Low | Low (consumed) |
| D-dimer | Normal | Normal | Very High (widespread clotting) |
Test your understanding!
A 72-year-old patient who has been in the ICU for 3 weeks with poor nutritional intake develops a prolonged PT/INR of 2.5 and a PTT of 50 seconds. You are asked to differentiate between vitamin K deficiency and underlying liver disease. You administer intravenous vitamin K.
What result would you expect to see on the repeat labs 12 hours later if the cause is vitamin K deficiency?
Show answer
If the cause is vitamin K deficiency, you would expect the PT/INR and PTT to significantly improve or completely normalize. The healthy liver now has the cofactor it needs to produce functional clotting factors.
Conclusion
In this lesson, you've moved beyond simply localizing a defect to understanding the "why" behind two of the most frequent causes of coagulopathy. You now have a practical framework for interpreting and differentiating these common clinical problems.
Key Takeaways:
- Both vitamin K deficiency and liver disease initially present with an isolated prolonged PT/INR because Factor VII has the shortest half-life.
- In severe cases, both conditions lead to prolongation of both the PT/INR and PTT.
- You can differentiate severe liver disease from severe vitamin K deficiency by checking a Factor V level (low in liver disease) or by observing the response to a therapeutic trial of vitamin K (correction indicates deficiency).
In our next lesson, we will focus on the coagulopathy induced by two of the most common anticoagulants. We'll build on what we learned about vitamin K antagonists (like warfarin) and contrast them with the mechanism and laboratory monitoring of heparin.